InterCure (NASDAQ:INCR) Shares Up 0.7% – Time to Buy?

InterCure Ltd. (NASDAQ:INCR) shares were up 0.7% during mid-day trading on Friday . The company traded as high as $1.3110 and last traded at $1.3110. Approximately 2,047 shares changed hands during trading, a decline of 91% from the average daily volume of 22,058 shares. The stock had previously closed at $1.3023.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of InterCure in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, InterCure currently has a consensus rating of “Sell”.

InterCure Trading Up 0.7%

The company has a current ratio of 1.85, a quick ratio of 1.09 and a debt-to-equity ratio of 0.27. The stock’s 50-day simple moving average is $1.48 and its 200 day simple moving average is $1.53.

About InterCure

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil.